Zymeworks(ZYME) - 2025 Q4 - Earnings Call Transcript

Zymeworks (NasdaqGS:ZYME) Q4 2025 Earnings call March 02, 2026 08:30 AM ET Company ParticipantsBijal Desai - Senior Vice President, FinanceJon Miller - Managing DirectorKenneth Galbraith - Chair, CEO and Interim CFOMayank Mamtani - Senior Managing Director and Group Head of HealthcarePaul Moore - Chief Scientific OfficerReni Benjamin - Managing DirectorSabeen Mekan - SVP and Chief Medical OfficerScott Platshon - Acting Chief Investment OfficerShrinal Inamdar - VP of Investor RelationsStephen Willey - Managi ...